Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-25T05:21:26.508Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychiatric Drugs and Treatment in Pregnancy

Published online by Cambridge University Press:  29 January 2018

De Wet Vorster
De Wet Vorster*
Affiliation:
Johannesburg General and Tara Hospitals, and Johannesburg Child Guidance Clinic
Get access Rights & Permissions [Opens in a new window]

Extract

The thalidomide tragedy in Europe has necessitated a re-examination of the use of tranquillizers and other drugs for the treatment of psychiatric conditions during pregnancy.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 111 , Issue 474 , May 1965 , pp. 431 - 438
Copyright
Copyright © Royal College of Psychiatrists, 1965 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Vorster, D. (1960). “An investigation into the part played by organic factors in childhood schizophrenia.” J. Ment. Sci., 106, 494–522.Google Scholar
2 James, W. (1963). “Control data for evaluation effect of psychotherapy in habitual spontaneous abortion.” Brit. J. Psychiat., 109, 81–83.Google Scholar
3 Lilienfeld, A. (1955). “Relationship of pregnancy and development of neuropsychiatric disorders in childhood.” Amer. J. Pub. Health, 45, 637–643.Google Scholar
4a Taussig, H. (1962). “Thalidomide and phocomelia.” Pediatrics, 30, 654–659.CrossRefGoogle Scholar
4b Taussig, H., (ed.) (1961). “Effect of Drug on Fetus.” Ibid., 28, 678.Google Scholar
5 Jacobs, J. (1962). “Drugs and foetal abnormalities.” Brit. med. J., ii, 407.Google Scholar
6 Evered, D. (1963). “Thalidomide and vitamins.” Ibid., i, 610.Google Scholar
7 Editorial, (1963). “More hazards of drugs in pregnancy.” Ibid., i, 138.Google Scholar
8 Pletcher, A. (1962). “Pharmacodynamics of MAO inhibitors of hydrazine type”, in Psychosomatic Medicine. Philadelphia: Lea & Fibiger.Google Scholar
9 Warkany, J. (1957). “Congenital malformations and pediatrics.” Pediatric Clinic, 19, 4, 983–991.Google Scholar
10 Wilson, J. (1959). “Experimental studies on congenital malformation.” J. Chron. Dis., 10, 2, 111–130.Google Scholar
11 Nyhan, W. (1961). “Toxicity of drugs in the neonatal period.” J. Pediat., 59, 1, 1–20.Google Scholar
12 Kallen, B. (1963). “Opinion and knowledge re abnormalities.” Svenska Lakartidningen, 60, 50–55.Google Scholar
13 Armitage, S. (1952). “Effects of barbiturates on behaviour of rat offspring as measured in learning and reasoning situation.” J. Comp. Physiol. Psychol., 45, 146–152.Google Scholar
14 Lesinski, J. (1957). “Data on effect of largactil on rat fetuses and extra-uterine development.” Ginek. Polska., 28, 669–672.Google Scholar
15 Roux, C. (1959). “Teratogenic action of prochlorperazine.” Arch. franc. Pediat., 16, 968–971.Google Scholar
16 Werboff, J. (1962). “Postnatal behavioural effects of tranquillisers administered to gravid rat.” Exp. Neurol., 6, 3, 263–269.Google Scholar
17 Werboff, J. (1961). “Behavioural effects of prenatal drug administration in the white rat.” Paed., 27, 318–323.Google Scholar
18 Werboff, J. (1963). “Learning deficit of offspring after administration of tranquillising drugs to mothers.” Nature, 1, 197, 106.Google Scholar
19 Berger, F. (1963). “Hazards of drugs in pregnancy.” Brit. med. J., i, 540.Google Scholar
20 Robson, J. (1963). “The production of foetal abnormalities in rabbits by imipramine.” Lancet, i, 638.Google Scholar
21 Lindsay, D. (1961). As quoted in reference 20.Google Scholar
22 Bacon, R. (1948). “Effects of electroshock on pregnancy in rat.” Proc. Soc. Exper. Biol. Med., 69, 287.Google Scholar
23 Sobel, D. (1960). “Fetal damage due to E.C.T., chlorpromazine, insulin and reserpine.” A.M.A. Arch. Gen. Psychiat., 2, 606–611.Google Scholar
24 Forsmann, H. (1955). “Follow-up study of 16 children whose mothers were given E.C.T. during gestation.” Acta Psychiat. et Neurol. Scand., 30, 437–441.Google Scholar
25 Schachter, M. (1960). “E.C.T. during pregnancy and embryopathy.” Acten paedopsychiat., 27, 289–292.Google Scholar
26 Kris, E. (1957). “Chlorpromazine maintenance therapy during pregnancy and confinement.” Quart. J. Psychiat., 31, 690–695.Google Scholar
27 Brougher, J. (1960). “Treatment of emotional disorders in obstetrics with thioridazine.” Quart. Rev. Surgery Obstets. Gynae., 17, 44–47.Google Scholar
28 Sippel, W. (1958). “Intramuscular promazine hydrochloride in obstetrics.” Rocky Mtn. Med., J., 55, 60–63.Google Scholar
29 Moesner, G. (1959). “Clinical evaluation of a meprobamate-promazine combination in control of nausea and vomiting of pregnancy.” J. Surg. Obstets. Gynae., 67, 180–182.Google Scholar
30 Sullivan, C. L. (1958). “Prochlorperazine for treatment of nausea and vomiting of early pregnancy.” New Engl. J. Med., 258, 232–234.Google Scholar
31 Birnberg, C. (1959). “Perphenazine suppositories in nausea of pregnancy.” Amer. J. Obstet. Gynec., 2, 438–441.Google Scholar
32 Harer, W. (1958). “Tranquillisers in obstetrics and gynecology. Studies with trilafon.” Obstet. and Gynec., 11, 273–279.Google Scholar
33 Schire, T. (1963). “Trifluoperazine and fetal abnormality.” Lancet, i, 174.CrossRefGoogle Scholar
34 Dally, P. (1960). “Comparative trial of phenelzine and other drugs in depression.” Symposium on Depression. Royal College of Surgeons.Google Scholar
35 Neilson, D. (1959). “Clinical evaluation of iproniazid in obstetrics.” Trans. Pacif. Coast Obstet. and Gynec. Soc., 27, 31–39.Google Scholar
36 Lees, F. (1963). “Tranylcypromine.” Lancet, i, 13.Google Scholar
37 Adriani, J. (1962). “Amphetamine therapy during pregnancy.” J.A.M.A., 182, 2, 221.Google Scholar
38 Sargant, W. (1963). “Drugs for depression.” Brit. med. J., i, 402.Google Scholar
39 McBride, W. (1962). “Drugs and foetal abnormalities.” Ibid., ii, 1681.Google Scholar
40 Mellin, G. (1962). “The saga of thalidomide: neuropathy to embryopathy, with case reports of congenital anomalies.” New Engl. J. Med., 267, 1184–1193.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.